It is caused by a channelopathy, which is a mutation in an ion channel in muscle
Market Size & Forecast (2024-2031), By Drug Type, USD Billion Prescription Drugs OTC Drugs Market Size & Forecast (2024-2031), By Distribution Channel, USD Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies/E-commerce Market Size & Forecast (2024-2031), By Region, USD Billion North America US Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Latin America Middle East & Africa Key Strategic Questions Addressed in this Report What is the market size & forecast of the obesity drugs market
Pharmacokinetics of prednisolone transfer to breast milk
Improved Glucose Regulation Beyond weight loss, cagrilintide shows promise in improving glycemic control
Treating individuals with obesity and impaired glucose metabolism with GLP-1 receptor agonists has already been reported to prevent the onset of diabetes, at least for a treatment period lasting 1 or 2 years [17]
)
